|
RNF7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69531055860261E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.48529996582647E-09 |
| Normal-vs-Stage2 |
1.775650E-02 |
| Normal-vs-Stage3 |
2.28300001126058E-09 |
| Normal-vs-Stage4 |
9.64517354873351E-12 |
| Stage1-vs-Stage2 |
6.657000E-01 |
| Stage1-vs-Stage3 |
7.189900E-02 |
| Stage1-vs-Stage4 |
4.957700E-04 |
| Stage2-vs-Stage3 |
1.273050E-01 |
| Stage2-vs-Stage4 |
1.128300E-02 |
| Stage3-vs-Stage4 |
1.643770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.09166017839379E-13 |
| Normal-vs-AfricanAmerican |
1.54517999999548E-05 |
| Normal-vs-Asian |
2.375400E-01 |
| Caucasian-vs-AfricanAmerican |
5.915600E-01 |
| Caucasian-vs-Asian |
3.021000E-01 |
| AfricanAmerican-vs-Asian |
2.122600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.06430000765567E-10 |
| Normal-vs-Female |
1.62725388719309E-12 |
| Male-vs-Female |
3.751900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.391900E-04 |
| Normal-vs-Age(41-60Yrs) |
3.74755781962222E-12 |
| Normal-vs-Age(61-80Yrs) |
5.05430031161325E-10 |
| Normal-vs-Age(81-100Yrs) |
1.787020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.645760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.958000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.046300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.015000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.881900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.115400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.4496000000005E-05 |
| Normal-vs-Grade 2 |
7.97999999413435E-10 |
| Normal-vs-Grade 3 |
1.17080012351778E-10 |
| Normal-vs-Grade 4 |
2.65409999533617E-08 |
| Grade 1-vs-Grade 2 |
5.839200E-01 |
| Grade 1-vs-Grade 3 |
7.525800E-01 |
| Grade 1-vs-Grade 4 |
1.790420E-01 |
| Grade 2-vs-Grade 3 |
5.390000E-01 |
| Grade 2-vs-Grade 4 |
7.617900E-03 |
| Grade 3-vs-Grade 4 |
1.949650E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.5165979583287E-11 |
| Normal-vs-ccB subtype |
4.2498999996976E-07 |
| ccA subtype-vs-ccB subtype |
6.059800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.03829961190161E-10 |
| Normal-vs-N1 |
8.197700E-04 |
| N0-vs-N1 |
1.050000E-02 |
|
|
